Abstract:
A method of producing 2-phenoxyacetals of the general formula (Ia) is likewise described in which R1 is hydrogen, a branched or unbranched C1-C12-alkyl moiety, a low-electron, halogen-NO2-, -CN, -CF3-, acyl- or branched or unbranched alkyl-substituted or unsubstituted C5-C6-aryl or heteroaryl moiety and R2 is a branched or unbranched C1-C5-alkyl moiety or both R2 moieties are directly linked to one another or via a C1-C4 unit, one Y is always hydrogen and the other Y is an -NO2, -CN or -CF3 moiety or fluorine or chlorine or both Y moieties each independently of one another are an NO2-, CN- or CF3-moiety or fluorine or chlorine, Z is hydrogen or an -NO2 moiety or branched or unbranched C1-C6-alkyl moiety or acyl moiety, by reacting a 2-hydroxyacetal compound of the general formula (II) in which R1 and R2 have the meaning given for formula (Ia) with a substituted aromatic of the general formula (III) in which Y has the meaning given for formula (I) and Y is fluorine, chlorine, bromine or an NO2 group, in the presence of a base. A method of producing the corresponding 2-phenoxycarbaldehydes by acid hydrolysis of the 2-phenoxyacetals is likewise described.
Abstract:
Methods are provided for making certain 6,7-dihalo-1,5-dihydroimidazo [2,1-b] quinazolin-2 (3H) -ones from 2,3-dihalobenzaldehydes. A method is also provided for making the intermediate ethyl N-(2,3-dihalo-6-nitrobenzyl)glycines from 2,3-dihalobenzaldehydes and for reducing the glycine compounds using either SnCl 2 or a specially defined catalyst. A cyclization method to form the desired 6,7-dihalo-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-ones from the corresponding iminoquinazoline compounds is further provided. These methods are particularly suitable in the manufacture of Anagrelide base.
Abstract:
Described is a process for preparing diaryl ethers of the formula (I)
Ar-O-Ar' (I)
In which Ar is an aryl or substituted aryl group and Ar' is an aryl, substituted aryl, heteroaryl or substituted heteroaryl group, by reacting an aryl of formula (II) or a aryloxy salt of formula (III)
Ar-OH (II)
Ar-OR (III)
In which Ar has the same meaning as in formula (I) and R is an alkali metal, with an aryl or heteroaryl bromide of formula (IV)
Ar'-Br (IV)
In which Ar' has the same meaning as in formula (I), characterized in that the reaction is carried out in the presence of a copper(I)salt and a 1-substituted imidazole as catalyst system.
Abstract:
The invention is directed to a phosphine compound represented by general formula (1) wherein R' and R' independently are selected from alkyl, cycloalkyl and 2-furyl radicals, or R' and R' are joined together to form with the phosphorous atom a carbon-phosphorous monocycle comprising at least 3 carbon atoms or a carbon- phosphorous bicycle; the alkyl radicals, cycloalkyl radicals, and carbon-phosphorous monocycle being unsubstituted or substituted by at least one radical selected from the group of alkyl, cycloalkyl, aryl, alkoxy, and aryloxy radicals; Cps is a partially substituted or completely substituted cyclopentadien-1-yl group, including substitutions resulting in a fused ring system, and wherein a substitution at the 1- position of the cyclopentadien-1-yl group is mandatory when the cyclopentadien-1-yl group is not part of a fused ring system or is part of an indenyl group. Also claimed is the use of these phosphines as ligands in catalytic reactions and the preparation of these phosphines.
Abstract:
A method for producing an optically active nitro compound having two hydrogen atoms on its α-carbon atom and having β-asymmetric carbon atom which comprises making an α, β-unsaturated nitroolefin having a hydrogen atom on its α-carbon atom react with at least one organosilicon compound having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex and water.
Abstract:
The present invention refers to new derivatives of the penta-1,4-dien-3-ones, as well as their processes of preparation. These compounds present strong antitumoral activity and promising antiparasitic action, behaving as almost atoxic by laboratory assays and also by hystopathologic studies. The present invention refers also to a pharmaceutical composition consisting of the referred compounds, method of treatment for cancer and parasitic diseases.
Abstract:
The present invention has its object to provide a method for producing an optically active hydroxycarboxylic acid derivative which is an intermediate important for production of medicines, agrochemicals, chemical products, and so on. The production method of the present invention comprises: carrying out a hydrogen-transfer reduction of a ketocarboxylic acid or a salt thereof by the reaction of an optically active diamine complex to produce an optically active hydroxycarboxylic acid derivative. According to the present invention, it is possible to safely and efficiently produce an industrially-useful optically active hydroxycarboxylic acid derivative.
Abstract:
A process for producing a dicarboxylic acid compound represented by the formula (4):
wherein R 1 and R 2 are the same or different and each represents lower alkyl and the wavy line indicates that this compound is the E- or Z-isomer or a mixture of them, characterized by reacting a compound represented by the formula (2):
wherein R 1 , R 2 and the wavy line have the same meanings as the above, and one of X 2 and X 3 represents hydrogen and the other represents halogen, with nitrophenol represented by the formula (3):
in the presence of a base; a process for producing a nitrochromone compound represented by the formula (5):
wherein R 1 has the same meaning as the above, characterized by reacting the dicarboxylic acid compound or carboxylic acid thereof with an acid; a process for producing an aminochromone compound which comprises reducing the nitrochromone compound; and a process for producing an amidochromone compound which comprises acylating the aminochromone compound are provided.
Abstract:
A reactor apparatus includes at least one reaction capillary having a lumen for receiving a reactant to undergo a reaction, and a magnetron for irradiating reactant contained in at least a portion of the capillary with microwaves. A method of micro-reacting a reactant includes providing a capillary, and irradiating the reactant in the capillary with microwaves to facilitate a chemical reaction in the capillary by which the reactant is converted into a desired product.
Abstract:
The invention is directed to a phosphine compound represented by general formula (1)
wherein R' and R" independently are selected from alkyl, cycloalkyl and 2-furyl radicals, or R' and R" are joined together to form with the phosphorous atom a carbon-phosphorous monocycle comprising at least 3 carbon atoms or a carbon-phosphorous bicycle; the alkyl radicals, cycloalkyl radicals, and carbon-phosphorous monocycle being unsubstituted or substituted by at least one radical selected from the group of alkyl, cycloalkyl, aryl, alkoxy, and aryloxy radicals; Cp s is a partially substituted or completely substituted cyclopentadien-1-yl group, including substitutions resulting in a fused ring system, and wherein a substitution at the 1-position of the cyclopentadien-1-yl group is mandatory when the cyclopentadien-1-yl group is not part of a fused ring system or is part of an indenyl group. Also claimed is the use of these phosphines as ligands in catalytic reactions and the preparation of these phosphines.